Related Experiment Video
Updated: Oct 30, 2025
06:22
Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
Published on: April 7, 2021
3.6K
Acute respiratory distress syndrome
Nuala J Meyer1, Luciano Gattinoni2, Carolyn S Calfee3
1Pulmonary, Allergy and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
Lancet (London, England)
|July 4, 2021
Summary
Acute respiratory distress syndrome (ARDS) presents challenges in diagnosis and treatment, with high mortality rates. This review covers ARDS epidemiology, management strategies, and COVID-19-specific considerations.
Area of Science:
- Pulmonology
- Critical Care Medicine
- Infectious Diseases
Background:
- Acute Respiratory Distress Syndrome (ARDS) is a severe lung injury characterized by hypoxemia and pulmonary edema.
- The COVID-19 pandemic has increased ARDS incidence, revealing treatment limitations and high mortality.
- Effective pharmacotherapy for ARDS remains elusive.
Purpose of the Study:
- To summarize current knowledge on ARDS epidemiology, risk factors, and diagnosis.
- To review evidence-based clinical management, including mechanical ventilation and supportive care.
- To discuss controversies and future research directions in ARDS, including COVID-19-associated ARDS.
Main Methods:
- Literature review and synthesis of existing research on ARDS.
- Analysis of epidemiological data and risk factors.
- Evaluation of clinical management strategies and outcomes.
Main Results:
- ARDS affects diverse patient populations with varied risk factors.
- Mechanical ventilation and supportive care are cornerstones of ARDS management.
- COVID-19-associated ARDS shares similarities but also has distinctions with other ARDS etiologies.
Conclusions:
- ARDS remains a significant clinical challenge with high mortality.
- Further research is needed to develop effective pharmacotherapies for ARDS.
- Understanding COVID-19-associated ARDS is crucial for optimizing patient care.
Related Concept Videos
01:23Acute Respiratory Failure-IV
302
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
302
01:21Acute Respiratory Failure-I
456
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
456
01:21Acute Respiratory Failure-II
569
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
569
01:30Acute Respiratory Failure-III
425
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
425
01:29Acute Respiratory Failure-V
250
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
250
01:23Assessment of Respiration
1.4K
The respiratory system's basic structures and primary functions lay the foundation for nurses' comprehensive respiratory assessments. This assessment includes subjective and objective data to gauge the patient's respiratory health.
Subjective Assessment: Nurses interview the patient to gather information directly during the subjective assessment. It includes questions about the individual's medical history, medications, and symptoms, focusing on past respiratory conditions like...
Subjective Assessment: Nurses interview the patient to gather information directly during the subjective assessment. It includes questions about the individual's medical history, medications, and symptoms, focusing on past respiratory conditions like...
1.4K